BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan J, Cui Z. Self-Assembled Nanoparticles: Exciting Platforms for Vaccination. Biotechnol J 2020;15:e2000087. [PMID: 33411412 DOI: 10.1002/biot.202000087] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Jung Lee I, Lan Y, Wu P, Wu Y, Chen Y, Tseng S, Kuo T, Sun C, Jan J, Ma H, Liao C, Liang J, Ko H, Chang C, Liu W, Ko Y, Chen Y, Sie Z, Tsung S, Lin Y, Hsuan Wang I, Tao M. A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern. Emerging Microbes & Infections 2022. [DOI: 10.1080/22221751.2022.2149353] [Reference Citation Analysis]
2 Kou S, Chen W, Sun C, Sun F. SpyStapler-mediated assembly of nanoparticle vaccines. Nano Res . [DOI: 10.1007/s12274-022-4951-9] [Reference Citation Analysis]
3 Qiao Y, Zhang Y, Chen J, Jin S, Shan Y. A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice. Nano Res . [DOI: 10.1007/s12274-022-4482-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lee J, Kim D, Byun J, Wu Y, Park J, Oh YK. In vivo fate and intracellular trafficking of vaccine delivery systems. Adv Drug Deliv Rev 2022;186:114325. [PMID: 35550392 DOI: 10.1016/j.addr.2022.114325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Santhosh SK, Kootery KP, Umesh M, Alex PM, Mani M, Roy A, Sarojini S. Nanovaccinology and Superbugs. Nanovaccinology as Targeted Therapeutics 2022. [DOI: 10.1002/9781119858041.ch3] [Reference Citation Analysis]
6 Mangla B, Javed S, Sultan MH, Ahsan W, Aggarwal G, Kohli K. Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit. Front Pharmacol 2021;12:757761. [PMID: 35087403 DOI: 10.3389/fphar.2021.757761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Read BJ, Won L, Kraft JC, Sappington I, Aung A, Wu S, Bals J, Chen C, Lee KK, Lingwood D, King NP, Irvine DJ. Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens. Cell Rep 2022;38:110217. [PMID: 35021101 DOI: 10.1016/j.celrep.2021.110217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Wallin K, Zhang R, Schmidt-dannert C. Programmable Self-Assembling Protein Nanomaterials: Current Status and Prospects. Engineered Living Materials 2022. [DOI: 10.1007/978-3-030-92949-7_3] [Reference Citation Analysis]
9 Tabarzad M, Mohit E, Ghorbani-bidkorbeh F. Nanovaccines delivery approaches against infectious diseases. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00002-6] [Reference Citation Analysis]
10 Martínez-Flores D, Zepeda-Cervantes J, Cruz-Reséndiz A, Aguirre-Sampieri S, Sampieri A, Vaca L. SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants. Front Immunol 2021;12:701501. [PMID: 34322129 DOI: 10.3389/fimmu.2021.701501] [Cited by in Crossref: 61] [Cited by in F6Publishing: 71] [Article Influence: 61.0] [Reference Citation Analysis]
11 Oliveira MB, Li F, Choi J, Mano JF. Nanomaterials for Biomedical Applications. Biotechnol J 2020;15:e2000574. [PMID: 33283977 DOI: 10.1002/biot.202000574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]